---
title: "Cipla: Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) — FDA announcement Jul 7, 2023 | Is It on Recall"
description: "Failure to deliver the recommended dose"
url: https://isitonrecall.com/recall/fdapress-d70c8614d54531f4-cipla-albuterol-sulfate-inhalation-aerosol-90-mcg-200-metered-inhalation/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# Cipla: Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) — FDA announcement Jul 7, 2023

Reported terminated

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jul 7, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation)
- **Reason**: Failure to deliver the recommended dose
- **Classification**: Not supplied
- **Recalling firm**: Cipla
- **Quantity**: Not supplied
- **Agency-reported status**: Terminated in FDA listing
- **Source record identifier**: d70c8614d54531f4

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cipla-issues-voluntary-nationwide-recall-six-batches-albuterol-sulfate-inhalation-aerosol-90-mcg-200)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | The company is initiating a recall in the US due to a market complaint for one single inhaler (Batch Number - IB20056), where leakage was observed through the inhaler valve. Out of an abundance of precaution, the above mentioned 6 batches manufactured using the same lot of valves are being recalled.; Sr. No. \| Product Name \| Batch No. \| Expiry Date; 1. \| Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) \| IB20045 \| Nov.2023; 2. \| Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) \| IB20055 \| Nov.2023; 3. \| Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) \| IB20056 \| Nov.2023; 4. \| Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) \| IB20057 \| Nov.2023; 5. \| Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) \| IB20059 \| Nov.2023; 6. \| Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) \| IB20072 \| Nov.2023 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

**FDA company announcement, table 1**

| Sr. No. | Product Name | Batch No. | Expiry Date |
| --- | --- | --- | --- |
| 1. | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20045 | Nov.2023 |
| 2. | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20055 | Nov.2023 |
| 3. | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20056 | Nov.2023 |
| 4. | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20057 | Nov.2023 |
| 5. | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20059 | Nov.2023 |
| 6. | Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) | IB20072 | Nov.2023 |

Announcement retrieved Oct 1, 2026. [Official announcement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cipla-issues-voluntary-nationwide-recall-six-batches-albuterol-sulfate-inhalation-aerosol-90-mcg-200).

## Distribution

The product is used for the treatment and prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise induced bronchospasm. The product is packaged in 17ml plain aluminium aerosol canister integrated with dose counter coupled with plastic actuator and dust cap, each pack claims 200 metered inhalations and associated codes NDC-69097-142-60. These 6 batches were distributed Nationwide to wholesalers and retailers.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Alaska](https://isitonrecall.com/state/alaska/)
- [Alabama](https://isitonrecall.com/state/alabama/)
- [Arkansas](https://isitonrecall.com/state/arkansas/)
- [Arizona](https://isitonrecall.com/state/arizona/)
- [California](https://isitonrecall.com/state/california/)
- [Colorado](https://isitonrecall.com/state/colorado/)
- [Connecticut](https://isitonrecall.com/state/connecticut/)
- [Delaware](https://isitonrecall.com/state/delaware/)
- [Florida](https://isitonrecall.com/state/florida/)
- [Georgia](https://isitonrecall.com/state/georgia/)
- [Hawaii](https://isitonrecall.com/state/hawaii/)
- [Iowa](https://isitonrecall.com/state/iowa/)
- [Idaho](https://isitonrecall.com/state/idaho/)
- [Illinois](https://isitonrecall.com/state/illinois/)
- [Indiana](https://isitonrecall.com/state/indiana/)
- [Kansas](https://isitonrecall.com/state/kansas/)
- [Kentucky](https://isitonrecall.com/state/kentucky/)
- [Louisiana](https://isitonrecall.com/state/louisiana/)
- [Massachusetts](https://isitonrecall.com/state/massachusetts/)
- [Maryland](https://isitonrecall.com/state/maryland/)
- [Maine](https://isitonrecall.com/state/maine/)
- [Michigan](https://isitonrecall.com/state/michigan/)
- [Minnesota](https://isitonrecall.com/state/minnesota/)
- [Missouri](https://isitonrecall.com/state/missouri/)
- [Mississippi](https://isitonrecall.com/state/mississippi/)
- [Montana](https://isitonrecall.com/state/montana/)
- [North Carolina](https://isitonrecall.com/state/north-carolina/)
- [North Dakota](https://isitonrecall.com/state/north-dakota/)
- [Nebraska](https://isitonrecall.com/state/nebraska/)
- [New Hampshire](https://isitonrecall.com/state/new-hampshire/)
- [New Jersey](https://isitonrecall.com/state/new-jersey/)
- [New Mexico](https://isitonrecall.com/state/new-mexico/)
- [Nevada](https://isitonrecall.com/state/nevada/)
- [New York](https://isitonrecall.com/state/new-york/)
- [Ohio](https://isitonrecall.com/state/ohio/)
- [Oklahoma](https://isitonrecall.com/state/oklahoma/)
- [Oregon](https://isitonrecall.com/state/oregon/)
- [Pennsylvania](https://isitonrecall.com/state/pennsylvania/)
- [Rhode Island](https://isitonrecall.com/state/rhode-island/)
- [South Carolina](https://isitonrecall.com/state/south-carolina/)
- [South Dakota](https://isitonrecall.com/state/south-dakota/)
- [Tennessee](https://isitonrecall.com/state/tennessee/)
- [Texas](https://isitonrecall.com/state/texas/)
- [Utah](https://isitonrecall.com/state/utah/)
- [Virginia](https://isitonrecall.com/state/virginia/)
- [Vermont](https://isitonrecall.com/state/vermont/)
- [Washington](https://isitonrecall.com/state/washington/)
- [Wisconsin](https://isitonrecall.com/state/wisconsin/)
- [West Virginia](https://isitonrecall.com/state/west-virginia/)
- [Wyoming](https://isitonrecall.com/state/wyoming/)

## Dates in the source

- **Fda listing date**: Jul 7, 2023
- **Company announcement date**: Jul 6, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers with questions adverse reactions or quality problems regarding these 6 batches can contact Cipla Customer Service at 844- CIPLAUS (844-247-5287) M-F 8:30-5:00 EST, or email cipla.cs@cipla.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cipla-issues-voluntary-nationwide-recall-six-batches-albuterol-sulfate-inhalation-aerosol-90-mcg-200)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Albuterol records](https://isitonrecall.com/drug/albuterol/) [Medications records](https://isitonrecall.com/category/medications/) [CIPLA records](https://isitonrecall.com/brand/cipla/)
